Skip to content
Education
Isle of NAM
Synthetic Biology

Synthetic Biology

Table of Contents

Definition

Synthetic biology is the engineering of biology: it brings together engineers and biologists to design and build novel biomolecular components, networks, and pathways, and to use these constructs to rewire and reprogram organisms1. Early definitional work framed the discipline as comprising two subfields: one that uses unnatural molecules to reproduce emergent behaviors from natural biology, with the goal of creating artificial life, and one that seeks interchangeable parts from natural biology to construct systems that do not exist in nature2.

The field models living cells as programmable information-processing systems. Its constructions operate through endogenous cellular mechanics, namely transcription, translation, and signal transduction: promoters, ribosome binding sites, protein coding sequences, terminators, and regulatory proteins are composed into devices that sense inputs, process information, and regulate outputs, frequently through feedback control3. Engineered circuits emulate and extend natural regulatory motifs; the first synthetic circuits demonstrated bistability, through the genetic toggle switch constructed in Escherichia coli4, and oscillation, through the repressilator, a synthetic network of transcriptional repressors5.

The discipline was formalized through proposals to practice biology as an engineering discipline founded on the standardization of parts, the abstraction of design into parts, devices, and systems, and the decoupling of design from fabrication6. Historical accounts date the coalescence of the field to these early demonstrations and to the concurrent formation of shared community infrastructure7.

Purpose

The primary value proposition is predictability. Where legacy biotechnology depended on empirical strain improvement, random mutagenesis, and trial-and-error optimization, synthetic biology substitutes model-driven, rational design in which standardized parts are composed into systems whose behavior is specified in advance6 3. Abstraction and standardization permit the design of a system to proceed independently of its physical assembly, and allow predictive composition of parts into devices and devices into systems6.

In production contexts, engineered biosynthesis replaces two legacy supply models: the extraction of scarce natural products from biological sources and the chemical synthesis of molecules from nonrenewable feedstocks. Metabolic engineering can produce, from simple, readily available, inexpensive starting materials, a large number of chemicals that are currently derived from nonrenewable resources or from natural products in limited supply8. The semi-synthetic artemisinin program exemplifies this substitution: engineered yeast fermentation replaced dependence on the agricultural supply of Artemisia annua for the precursor artemisinic acid, thereby stabilizing production of a front-line antimalarial medicine9.

The human relevance is direct. Engineered biological systems have been used to manipulate information, construct materials, process chemicals, produce energy, provide food, and help maintain or enhance human health and the environment6. Reviews of the field survey applications spanning therapeutics, diagnostics, and vaccine-relevant technologies, positioning synthetic biology as a platform discipline for human medicine1.

Methodology

Construction proceeds through a design-build-test-learn cycle organized under an abstraction hierarchy, in which standardized parts such as promoters, ribosome binding sites, coding sequences, and terminators are composed into devices, and devices into systems6 3. The design substrate is DNA, and chassis organisms such as Escherichia coli and Saccharomyces cerevisiae serve as the host vehicles for engineered constructs1 9.

Genes and pathways are fabricated by large-scale de novo DNA synthesis, using oligonucleotide synthesis, gene assembly, and error correction, or are obtained from commercial synthesis providers10. Physical assembly employs standardized protocols. The BioBrick standard flanks each part with defined prefix and suffix sequences so that parts are joined idempotently, and the composite part remains itself a valid part compatible with further assembly11. Gibson isothermal assembly is a one-tube enzymatic reaction, combining a 5-prime exonuclease, a DNA polymerase, and a ligase, that joins overlapping DNA fragments into constructs up to several hundred kilobases, including entire bacterial genomes12. For substrates, protocols typically specify synthetic oligonucleotides, plasmid vectors, and defined growth media for the chassis strain; for growth factors and regulatory elements, protocols specify inducers such as small-molecule effectors that control promoter activity3 11.

Genome-level edits employ CRISPR-Cas programmable nucleases, in which a dual-RNA guide directs the Cas9 endonuclease to cleave chosen DNA targets, establishing a general mechanism for targeted genome modification13. Circuit design is supported by codified design principles addressing how the choice of regulatory tools and the cellular host affect circuit behavior, and by insulation strategies that stabilize gate performance across genetic contexts3. Design automation environments such as Cello translate user-written Verilog specifications into DNA sequences, automating part assignment, gate connection, and performance simulation14. Community resources, including standardized part registries associated with the BioBrick movement, disseminate these tools and conventions11 7.

Performance

Empirical performance benchmarks demonstrate the capacity and the limits of the approach. In a landmark design-automation study, sixty circuits were designed for Escherichia coli, totaling 0.88 megabase pairs of DNA, and each DNA sequence was built as predicted by the software with no additional tuning; of these, forty-five circuits performed correctly, and across the full set 92 percent of the output states functioned as predicted, with the largest circuits containing ten regulators and fifty-five parts14. Earlier milestones include orthogonal AND logic gates assembled from DNA-binding proteins into complex layered circuits in single cells15, and recombinase-based synthetic circuits integrating logic and memory, with memory states maintained for at least ninety cell generations16. In production contexts, engineered Saccharomyces cerevisiae reached artemisinic acid titers of 25 grams per liter, coupled with a four-step chemical conversion to artemisinin9. At genome scale, the minimal cell JCVI-syn3.0 carries a 531,560-base-pair genome with 473 genes, derived from the 1,079-kilobase-pair synthetic genome JCVI-syn1.0 through systematic minimization17.

Reproducibility depends on the insulation of devices from genetic context, so that parts function identically when used in different circuits; standardized part collections and automated design pipelines measurably raise first-attempt success rates relative to manual assembly3 14.

Current technical boundaries remain material. The expression of engineered constructs imposes metabolic burden on host cells, which distorts circuit performance and constrains circuit size; burden-driven CRISPR feedback controllers, in which guide RNA expression is triggered by the burden of protein overexpression and directs repression of the exogenous promoter, have been developed to manage this constraint18. The gap between designed and realized behavior, in which fifteen of the sixty computationally designed circuits failed to perform correctly, indicates that predictive design models remain incomplete14. Part behavior also varies with the choice of tools and with the host cellular context, requiring explicit compensation during design3.

Applications

In primary research, synthetic circuits serve as instruments for testing hypotheses about cellular regulation, exemplified by the engineered bistable and oscillatory networks that established that designed circuits can reproduce dynamic behaviors of natural regulatory systems4 5. Minimal synthetic cells function as models for defining the essential machinery required for life17. Construction itself operates as an epistemic tool: a synthetic objective compels researchers to engage and resolve issues that cannot be readily resolved by analysis alone2.

In industrial application, the flagship deployment is the semi-synthetic production of artemisinin, developed to manufacturing scale for pharmaceutical supply9. More broadly, metabolic engineering targets the renewable production of chemicals, materials, and fuels from simple starting materials8, and the commercial DNA synthesis industry supplies designed constructs as its fabrication backbone10.

Standardized contexts of use include the BioBrick part standard and its associated registries, together with community institutions through which these standards were disseminated11 7. Deployment stages vary by application. Single-pathway production systems have reached industrial deployment, as in the artemisinin program9. Cell-free systems now serve as platforms for rapid prototyping and for field-deployable diagnostics, including freeze-dried biosensing formats that circumvent the constraints of living hosts19 20. Automated circuit design shortens development timelines and is intended to simplify the incorporation of decision-making circuits into biotechnology projects14. Readiness remains uneven: pathway-level applications are commercially deployed, whereas larger, multi-device biological programs remain predominantly at the laboratory stage, with ongoing expansion towards more complex therapeutic and diagnostic systems1.

Variations

  • Genetic Circuit Engineering: the construction of engineered regulatory networks that implement digital logic, memory, and oscillation in single cells, exemplified by the toggle switch and the repressilator and extended to layered logic gates and recombinase-based state machines4 5 15 16.
  • Metabolic Engineering: the redirection of cellular metabolism through heterologous pathway design so that microbial hosts produce target molecules, exemplified by the artemisinin precursor program8 9.
  • Genome Synthesis and Minimal Genomes: the top-down chemical synthesis of complete genomes and their systematic minimization to define the minimal set of genes required to sustain cellular life17.
  • Cell-Free Synthetic Biology: the execution of transcription and translation in cell extracts rather than living cells, supporting rapid prototyping and field-deployable biosensing19 20.
  • Xenobiology: the construction of biological systems founded on noncanonical chemistries, such as xeno nucleic acids orthogonal to natural biochemistry, proposed as an intrinsic biosafety mechanism21.

  1. Khalil AS, Collins JJ, Synthetic biology: applications come of age, Nature Reviews Genetics, 2010-05.
    A review defining synthetic biology as the effort to bring together engineers and biologists to design and build novel biomolecular components, networks, and pathways, and to use these constructs to rewire and reprogram organisms. It surveys the maturing application space across human medicine and biotechnology, and it grounds the claim that engineered biological programs are expanding beyond small gene networks. ↩︎ ↩︎ ↩︎ ↩︎

  2. Benner SA, Sismour AM, Synthetic biology, Nature Reviews Genetics, 2005-07.
    An early definitional review of the discipline. It frames synthetic biology as comprising two subfields, one that uses unnatural molecules to reproduce emergent behaviors from natural biology with the goal of creating artificial life, and one that seeks interchangeable parts from natural biology to construct systems that do not exist in nature. It also articulates the principle that a synthetic objective compels researchers to resolve issues that cannot be readily resolved by analysis alone. ↩︎ ↩︎

  3. Brophy JA, Voigt CA, Principles of genetic circuit design, Nature Methods, 2014-05.
    A review of the design principles underlying transcriptional circuits. It introduces the tools used to build engineered regulatory networks and explains how the choice of tools, the cellular host, and the surrounding genetic context affect circuit behavior. It supplies the vocabulary of parts, insulation, and context effects used throughout this page. ↩︎ ↩︎ ↩︎ ↩︎ ↩︎ ↩︎ ↩︎

  4. Gardner TS, Cantor CR, Collins JJ, Construction of a genetic toggle switch in Escherichia coli, Nature, 2000-01.
    The first synthetic gene circuit, a bistable toggle switch built in Escherichia coli from two mutually repressing transcriptional regulators and switchable by inducers. It demonstrated that a gene-regulatory network with a designed behavior could be constructed rationally in a living cell, catalyzing the emergence of the field. ↩︎ ↩︎ ↩︎

  5. Elowitz MB, Leibler S, A synthetic oscillatory network of transcriptional regulators, Nature, 2000-01.
    The repressilator, a three-gene synthetic network of transcriptional repressors arranged in a cyclic negative-feedback topology that produces sustained oscillations in Escherichia coli. Together with the toggle switch, it constitutes one of the two founding demonstrations that designed circuits can reproduce dynamic regulatory behaviors in vivo. ↩︎ ↩︎ ↩︎

  6. Endy D, Foundations for engineering biology, Nature, 2005-11.
    A programmatic essay proposing the foundations for practicing biology as an engineering discipline, based on the standardization of parts, abstraction into parts, devices, and systems, and decoupling of design from fabrication. It also enumerates the human-relevant uses of engineered biological systems, including chemicals, energy, food, health, and environmental applications. ↩︎ ↩︎ ↩︎ ↩︎ ↩︎

  7. Cameron DE, Bashor CJ, Collins JJ, A brief history of synthetic biology, Nature Reviews Microbiology, 2014-05.
    A timeline review charting the history of synthetic biology from its inception around the foundational gene circuits of 2000 through the subsequent decade, covering both technical milestones and the cultural and community infrastructure, including standard part registries and the iGEM competition, through which the field organized itself. ↩︎ ↩︎ ↩︎

  8. Keasling JD, Manufacturing molecules through metabolic engineering, Science, 2010-12.
    A review describing how metabolic engineering can produce, from simple, readily available, and inexpensive starting materials, a large number of chemicals that are currently derived from nonrenewable resources or from natural products in limited supply. It articulates the replacement rationale by which engineered biosynthesis supersedes petrochemical synthesis and low-yield extraction. ↩︎ ↩︎ ↩︎

  9. Paddon CJ, et al., High-level semi-synthetic production of the potent antimalarial artemisinin, Nature, 2013-04.
    Reports the engineering of a Saccharomyces cerevisiae strain producing artemisinic acid at fermentation titers of 25 grams per liter, together with a practical four-step chemical process converting artemisinic acid to artemisinin. The work constitutes the flagship industrial deployment of synthetic biology, developed to stabilize pharmaceutical supply of a front-line antimalarial independent of agricultural sourcing. ↩︎ ↩︎ ↩︎ ↩︎ ↩︎ ↩︎

  10. Kosuri S, Church GM, Large-scale de novo DNA synthesis: technologies and applications, Nature Methods, 2014-05.
    A review of the technologies for large-scale de novo DNA synthesis, covering oligonucleotide synthesis from arrays, gene assembly, error correction, and the applications of synthetic DNA across research and industry. It documents the fabrication infrastructure that underwrites the construction phase of synthetic biology. ↩︎ ↩︎

  11. Shetty RP, Endy D, Knight TF, Engineering BioBrick vectors from BioBrick parts, Journal of Biological Engineering, 2008-04.
    Describes the BioBrick standard for biological parts, in which defined prefix and suffix sequences enable idempotent assembly so that a composite of two parts remains itself a valid part, and extends these principles of part reuse and standardization to the plasmid vectors used to propagate parts. It is the primary citation for the standardization methodology of the parts paradigm. ↩︎ ↩︎ ↩︎ ↩︎

  12. Gibson DG, et al., Enzymatic assembly of DNA molecules up to several hundred kilobases, Nature Methods, 2009-05.
    Describes the one-tube isothermal assembly method in which a 5-prime exonuclease, a DNA polymerase, and a ligase act on overlapping DNA fragments to produce large constructs, including an entire bacterial genome. It is the principal assembly protocol for multi-fragment construction in modern synthetic biology. ↩︎

  13. Jinek M, et al., A programmable dual-RNA-guided DNA endonuclease in adaptive bacterial immunity, Science, 2012-08.
    Demonstrates that the Cas9 protein is a programmable dual-RNA-guided DNA endonuclease whose cleavage targets are specified by the guide RNA sequence. The work established the mechanistic basis for CRISPR genome editing, the principal genome-modification tool used in synthetic biology construction. ↩︎

  14. Nielsen AAK, et al., Genetic circuit design automation, Science, 2016-04.
    Reports the Cello design environment, in which user-written Verilog is automatically transformed into a DNA sequence encoding a genetic circuit. Sixty circuits were designed and built as predicted with no additional tuning; forty-five performed correctly, and 92 percent of output states functioned as predicted, with the largest circuits containing ten regulators and fifty-five parts. The study quantifies both the reproducibility gains of automated, insulated design and the residual reliability gap. ↩︎ ↩︎ ↩︎ ↩︎ ↩︎

  15. Moon TS, et al., Genetic programs constructed from layered logic gates in single cells, Nature, 2012-11.
    Reports the creation of orthogonal AND logic gates by combining DNA-binding proteins and their operators, and their integration into complex, layered circuits operating in single cells. It opened the design path toward programmable integrated genetic circuits and marked a scaling milestone in circuit complexity. ↩︎ ↩︎

  16. Siuti P, Yazbek J, Lu TK, Synthetic circuits integrating logic and memory in living cells, Nature Biotechnology, 2013-05.
    Reports recombinase-based synthetic circuits that integrate genetic logic and permanent memory in living cells, with memory states maintained for at least ninety cell generations and readable by fluorescent reporters and polymerase chain reaction. It established recombinase state machines as a durable architecture for cellular record-keeping. ↩︎ ↩︎

  17. Hutchison CA, et al., Design and synthesis of a minimal bacterial genome, Science, 2016-03.
    Reports the design, synthesis, and testing of the minimal synthetic cell JCVI-syn3.0, whose 531,560-base-pair genome contains 473 genes and was derived by systematic minimization of the 1,079-kilobase-pair synthetic genome JCVI-syn1.0. It is the defining result of the top-down genome minimization program and a working model of the minimal machinery required for cellular life. ↩︎ ↩︎ ↩︎

  18. Ceroni F, et al., Burden-driven feedback control of gene expression, Nature Methods, 2018-05.
    Demonstrates a CRISPR-based feedback controller in which guide RNA expression is triggered by the burden of protein overexpression and directs repression of the exogenous promoter, automatically reducing load on the host cell. It characterizes the metabolic burden of engineered expression as a principal technical boundary of the field and provides an engineered mitigation strategy. ↩︎

  19. Perez JG, Stark JC, Jewett MC, Cell-Free Synthetic Biology: Engineering Beyond the Cell, Cold Spring Harbor Perspectives in Biology, 2016-12.
    A review of cell-free approaches that execute transcription and translation in lysate extracts rather than living cells, positioning these systems as complements to in vivo methods. It covers cell-free platforms for prototyping, metabolic engineering, and biosensing, and documents the design freedom afforded by working beyond the constraints of a living host. ↩︎ ↩︎

  20. Tinafar A, Jaenes K, Pardee K, Synthetic Biology Goes Cell-Free, BMC Biology, 2019-08.
    A review arguing that cell-free systems have evolved into key platforms for synthetic biology, circumventing the constraints inherent to cellular hosts that have limited progress in cell-based implementations. It surveys applications of cell-free systems, including rapid prototyping and deployable biosensing formats such as freeze-dried paper-based assays. ↩︎ ↩︎

  21. Schmidt M, Xenobiology: a new form of life as the ultimate biosafety tool, BioEssays, 2010-04.
    Introduces xenobiology as the construction of biological systems founded on chemistries that do not occur in natural biochemistry, including orthogonal chromosomes built from xeno nucleic acids. It proposes such orthogonal systems as an intrinsic biocontainment mechanism, since organisms dependent on synthetic substrates cannot exchange genetic information with natural life. ↩︎